| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Mar 14, 2025 | Repare Therapeutics Inc. | CEO | Sell | 46.3 | -21,179 | -8.37% | ✗ | $24.1K |
| Mar 28, 2024 | Apr 1, 2024 | Repare Therapeutics Inc. | CEO | Sell | 45.0 | -5,141 | -2.39% | ✓ | $23.8K |
| Mar 25, 2024 | Mar 27, 2024 | Repare Therapeutics Inc. | CEO | Sell | 41.3 | -7,950 | -3.67% | ✓ | $37.3K |
| Jun 28, 2021 | Jun 30, 2021 | Repare Therapeutics Inc. | CEO | Sell | 45.0 | -1,542 | -1.53% | ✓ | $54.9K |
| Jun 9, 2021 | Jun 10, 2021 | Repare Therapeutics Inc. | CEO | Sell | 45.0 | -1,576 | -1.54% | ✓ | $55.2K |
| Jun 3, 2021 | Jun 7, 2021 | Repare Therapeutics Inc. | CEO | Sell | 17.5 | -41,000 | -28.55% | ✗ | $1.3M |
| May 20, 2021 | May 21, 2021 | Repare Therapeutics Inc. | CEO | Sell | 41.3 | -3,770 | -2.65% | ✓ | $132.1K |
| May 18, 2021 | May 20, 2021 | Repare Therapeutics Inc. | CEO | Sell | 37.5 | -5,600 | -3.78% | ✓ | $196.2K |
| Apr 15, 2021 | Apr 19, 2021 | Repare Therapeutics Inc. | CEO | Sell | 37.5 | -5,512 | -3.59% | ✓ | $193K |
| Jun 23, 2020 | Jun 25, 2020 | Repare Therapeutics Inc. | CEO | Buy | 87.5 | +5,000 | 3.37% | ✗ | $100K |